q-hERG: QUANTUM's innovative approach to hERG binding calculations is finally released

QUANTUM hERG (q-hERG) screening assays is a unique and innovative computational approach, which allows you to predict from a molecule structures of compounds their inhibition constants (IC50) for hERG channels.

q-hEARG features:

• Output is pIC50 values (-logIC50) for the molecules. The accuracy of prediction is 1.1 pIC50 units;
• No training sets or QSAR methods applied;
• hERG inhibition prediction is made by docking of compound on Quantum Pharmaceuticals’ Proprietary Flexible 3D structure of hERG;
• Docking is based on quantum and molecular physics (see Quantum Science Core for an overview);
• Average correlation has RMSD=1.18 pIC50 unit, and correlation coefficient = 0.82;
• Easy to use user interface, no special hardware requirements, both Linux/Windows supported;
• You can also request services based on QUANTUM hERG Screening Assays.

q-hERG is an independent software module, sharing the user interface and basic usage concepts with our q-ADME: ADME/PK properties prediction software, q-Mol: physico-chemical properties calculator, and q-Tox: toxicological profiling software. More information, including q-hERG product booklet can be obtained from the Quantum Pharmaceuticals products site.

Obtaining Q-Albumin software:

Please review your licensing options, add Q-Albumin: QUANTUM Albumin Binding Prediction Software to your shopping card and checkout to get the download links.

Licensing Options: One Month License $50,00 One Year License $100,00

And continue to CHECK OUT